Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03034213 · ClinicalTrials.gov registry record · NA
Gentrix™ Versus Biological or Prosthetic Mesh
A NA study, sponsored by University of South Florida.
- Terminated
- Registry status
- NA
- Development phase
- 17
- Enrollment target
NCT03034213 is a NA study that was terminated before completion, run by University of South Florida. The registered enrollment target is 17 participants.
The verdict
NCT03034213, a NA study, was terminated before completion, sponsored by University of South Florida.
- TERMINATED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
Study Summary
The hypothesis for this study is complex incisional hernia repair using the separation of components technique reinforced with retrorectus placement of Gentrix™ Surgical Matrix will lead to fewer incisional hernia recurrences and fewer wound complications compared to the same incisional hernia repair techniques reinforced with other prosthetic or biologically-derived mesh.
Interventions
- DEVICE Gentrix™ Surgical Matrix (Treatment)
- DEVICE Permacol, Parietex, Progrip, Strattice Perforated, or Surgimend (Control)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2017-10-06 |
| Est. Completion | 2021-06-16 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03034213
The ClinicalTrials.gov registry entry for NCT03034213 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of South Florida, which has 252 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Gentrix™ Surgical Matrix (Treatment) is the first listed.
NCT03034213 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03034213 about?
NCT03034213 is a clinical study titled "Gentrix™ Versus Biological or Prosthetic Mesh". The hypothesis for this study is complex incisional hernia repair using the separation of components technique reinforced with retrorectus placement of Gentrix™ Surgical Matrix will lead to fewer incisional hernia recurrences and fewer wound complications compared to the same incisional hernia repai...
What is the current status of trial NCT03034213?
This trial is currently terminated. It is a NA study. The enrollment target is 17 participants. The study started on 2017-10-06. Estimated completion is 2021-06-16.
What interventions are being tested in trial NCT03034213?
The interventions under investigation include: Gentrix™ Surgical Matrix (Treatment) (DEVICE), Permacol, Parietex, Progrip, Strattice Perforated, or Surgimend (Control) (DEVICE).
Who is sponsoring clinical trial NCT03034213?
This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.